E-LIB Suche - Ergebnisse für: Thuss-Patience, P.C.

1

424P Pembrolizumab and olaparib in advanced HER2-negative e..:

Haag, G.M. ; Goetze, T.O. ; Thuss-Patience, P.C....
Annals of Oncology. 35 (2024) - p. S172-S173 , 2024

Link: https://doi.org/10.1016/..

2

3558 POSTER Metastatic small bowel adenocarcinoma: favourab..:

Kretzschmar, A. ; Stahl, M. ; Hofheinz, R....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 276-277 , 2007

Link: https://doi.org/10.1016/..

3

Chemotherapy in alveolar soft part sarcomas:

Reichardt, P. ; Lindner, T. ; Pink, D....
European Journal of Cancer. 39 (2003) 11 - p. 1511-1516 , 2003

Link: https://doi.org/10.1016/..

4

Weekly combination of oxaliplatin (OX) and irinotecan (IRI)..:

Kretzschmar, A. ; Thuss-Patience, P.C. ; Pink, D....
European Journal of Cancer. 37 (2001) - p. S291 , 2001

Link: https://doi.org/10.1016/..

5

Capecitabine: The new standard in metastatic breast cancer ..:

Reichardt, P. ; von Minckwitz, G. ; Lück, H.J....
European Journal of Cancer. 37 (2001) - p. S191 , 2001

Link: https://doi.org/10.1016/..

6

Oxaliplatin (OX) after irinotecan (IRI): antitumour activit..:

Kretzschmar, A. ; Metzger, J. ; Thuss-Patience, P.C....
European Journal of Cancer. 35 (1999) - p. S81 , 1999

Link: https://doi.org/10.1016/..

7

Cisplatin /5-FU (DDP/FU) as 2nd-line chemotherapy after CPT..:

Thuss-Patience, P.C. ; Kretzschmar, A. ; Tilgner, J....
European Journal of Cancer. 35 (1999) - p. S149-S150 , 1999

Link: https://doi.org/10.1016/..

8

Standardisierte und qualitätsgesicherte prädiktive PD-L1-Te..:

Baretton, G. ; Lordick, F. ; Gaiser, T....
Die Pathologie. 45 (2024) 1 - p. 51-58 , 2024

Link: https://doi.org/10.1007/..

9

Standardized and quality-assured predictive PD-L1 testing i..:

Baretton, Gustavo B. ; Lordick, Florian ; Gaiser, T....
Journal of Cancer Research and Clinical Oncology. 149 (2023) 17 - p. 16231-16238 , 2023

Link: https://doi.org/10.1007/..

10

P11.15.A IMPACT OF PERIOPERATIVE DEXAMETHASONE IN THE CONTE..:

Wasilewski, D ; Bukatz, J ; Peukert, R...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii75-ii75 , 2023

Link: https://doi.org/10.1093/..

11

The OUTREACH study: oncologists of German university hospit..:

Biersching, T. ; Schweda, A. ; Oechsle, K....
Journal of Cancer Research and Clinical Oncology. 149 (2022) 7 - p. 2929-2936 , 2022

Link: https://doi.org/10.1007/..

12

Effects of a communication training for oncologists on earl..:

Harnischfeger, N. ; Rath, H.M. ; Alt-Epping, B....
ESMO Open. 7 (2022) 6 - p. 100623 , 2022

Link: https://doi.org/10.1016/..

13

Laparoskopische vs. offene Gastrektomie bei fortgeschritten..:

Raakow, J. ; Denecke, C. ; Chopra, S....
Der Chirurg. 91 (2019) 3 - p. 252-261 , 2019

Link: https://doi.org/10.1007/..

14

A multicentre, phase IIa study of zolbetuximab as a single ..:

Türeci, O. ; Sahin, U. ; Schulze-Bergkamen, H....
Annals of Oncology. 30 (2019) 9 - p. 1487-1495 , 2019

Link: https://doi.org/10.1093/..

15

Patients' perspectives towards malignant ascites: results o..:

Armbrust, Robert ; Neeb, C. ; Thuss-Patience, P....
Archives of Gynecology and Obstetrics. 299 (2019) 5 - p. 1385-1389 , 2019

Link: https://doi.org/10.1007/..